136 related articles for article (PubMed ID: 15170725)
1. Should we be using bilateral carotid distal protection devices during the percutaneous closure of patent foramen ovale in patients with a history of paradoxical embolus?
Richardson G; Keeble TR; Rothman MT
Catheter Cardiovasc Interv; 2004 Jun; 62(2):272-5. PubMed ID: 15170725
[TBL] [Abstract][Full Text] [Related]
2. Patent foramen ovale, systemic embolization and closure.
Holmes DR; Cohen H; Katz WE; Reeder GS
Curr Probl Cardiol; 2004 Feb; 29(2):56-94. PubMed ID: 15042045
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous occlusion of patent foramen ovale in patients with paradoxical embolism.
Pinto FF; Sousa L; Abreu J; Agapito A; Quininha J; Kaku S; Antunes AM
Rev Port Cardiol; 2001; 20(7-8):747-57; discussion 759-62. PubMed ID: 11582625
[TBL] [Abstract][Full Text] [Related]
4. Paradoxical embolization via a patent foramen ovale following acute pulmonary embolism.
Thomas DV; Bynevelt M; Price R
Australas Radiol; 2005 Dec; 49(6):501-4. PubMed ID: 16351617
[TBL] [Abstract][Full Text] [Related]
5. Resolution of migraine by transcatheter patent foramen ovale closure with Premere Occlusion System in a preliminary series of patients with previous cerebral ischemia.
Rigatelli G; Cardaioli P; Braggion G; Giordan M; Fabio D; Aggio S; Roncon L; Chinaglia M
Catheter Cardiovasc Interv; 2007 Sep; 70(3):429-33. PubMed ID: 17722021
[TBL] [Abstract][Full Text] [Related]
6. Interventional closure with Amplatzer PFO occluder of patent foramen ovale in patients with paradoxical cerebral embolism.
Chatterjee T; Petzsch M; Ince H; Rehders TC; Körber T; Weber F; Schneider H; Auf der Maur C; Nienaber CA
J Interv Cardiol; 2005 Jun; 18(3):173-9. PubMed ID: 15966921
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous closure of patent foramen ovale in patients with presumed paradoxical embolism: periprocedural results and midterm risk of recurrent neurologic events.
Balbi M; Casalino L; Gnecco G; Bezante GP; Pongiglione G; Marasini M; Del Sette M; Barsotti A
Am Heart J; 2008 Aug; 156(2):356-60. PubMed ID: 18657668
[TBL] [Abstract][Full Text] [Related]
8. [Percutaneous closure of patent foramen ovale, as secondary prevention of cryptogenic cerebral event].
Temesvári A; Bálint OH; Liptai C; Kancz S; Németh B; Szatmári A
Orv Hetil; 2006 Oct; 147(42):2035-9. PubMed ID: 17165604
[TBL] [Abstract][Full Text] [Related]
9. Exclusion of patients with arteriosclerosis reduces long-term recurrence rate of presumed arterial embolism after PFO closure.
Dubiel M; Bruch L; Liebner M; Schmehl I; Winkelmann A; Rux S; Sonntag S; Wulff H; Grad MO; Kleber FX
J Interv Cardiol; 2007 Aug; 20(4):275-81. PubMed ID: 17680857
[TBL] [Abstract][Full Text] [Related]
10. Combined percutaneous pulmonary valvuloplasty and patent foramen ovale closure in an adult with recurrent transient ischemic attacks.
Trani C; Rigattieri S; Mazzari MA; Lombardo A; Pennestrì F; Violini R; Pucci E; Crea F; Schiavoni G
Ital Heart J; 2002 Jul; 3(7):424-6. PubMed ID: 12189972
[TBL] [Abstract][Full Text] [Related]
11. Patent foramen ovale closure with the Intrasept occluder: Complete 6-56 months follow-up of 247 patients after presumed paradoxical embolism.
Spies C; Timmermanns I; Reissmann U; van Essen J; Schräder R
Catheter Cardiovasc Interv; 2008 Feb; 71(3):390-5. PubMed ID: 18288745
[TBL] [Abstract][Full Text] [Related]
12. Patent foramen ovale and ventricular septal defect closure.
Wahl A; Meier B
Heart; 2009 Jan; 95(1):70-82. PubMed ID: 19047442
[TBL] [Abstract][Full Text] [Related]
13. Long-term results after fluoroscopy-guided closure of patent foramen ovale for secondary prevention of paradoxical embolism.
Wahl A; Kunz M; Moschovitis A; Nageh T; Schwerzmann M; Seiler C; Mattle HP; Windecker S; Meier B
Heart; 2008 Mar; 94(3):336-41. PubMed ID: 17639093
[TBL] [Abstract][Full Text] [Related]
14. Stroke following variceal sclerotherapy.
Hanisch F; Müller T; Krivokuca M; Winterholler M
Eur J Med Res; 2004 May; 9(5):282-4. PubMed ID: 15257884
[TBL] [Abstract][Full Text] [Related]
15. Analysis of left and right ventricular Doppler tissue imaging in patients undergoing percutaneous closure of patent foramen ovale.
Yalonetsky S; Schwartz Y; Lorber A
J Invasive Cardiol; 2007 Jun; 19(6):252-4. PubMed ID: 17541124
[TBL] [Abstract][Full Text] [Related]
16. Incidence of extracerebral paradoxical embolisms in patients with intracardiac shunts.
Rigatelli G; Giordan M; Braggion G; Aggio S; Chinaglia M; Zattoni L; Milan T; Cardaioli P
Cardiovasc Revasc Med; 2007; 8(4):248-50. PubMed ID: 18053946
[TBL] [Abstract][Full Text] [Related]
17. Implantation of a second closure device in patients with residual shunt after percutaneous closure of patent foramen ovale.
Schwerzmann M; Windecker S; Wahl A; Nedeltchev K; Mattle HP; Seiler C; Meier B
Catheter Cardiovasc Interv; 2004 Dec; 63(4):490-5. PubMed ID: 15558761
[TBL] [Abstract][Full Text] [Related]
18. Rescue of CardioSEAL PFO closure device malposition with Amplatzer PFO closure device at time of initial implantation.
Hubbard R; Blankenship J; Haldis T
Catheter Cardiovasc Interv; 2007 Feb; 69(2):285-8. PubMed ID: 17253608
[TBL] [Abstract][Full Text] [Related]
19. Causes of recurrent focal neurologic events after transcatheter closure of patent foramen ovale with the CardioSEAL septal occluder.
Kutty S; Brown K; Asnes JD; Rhodes JF; Latson LA
Am J Cardiol; 2008 May; 101(10):1487-92. PubMed ID: 18471463
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous closure of a patent foramen ovale via left axillary vein approach with the Amplatzer Cribriform septal occluder.
Carter LI; Cavendish JJ
J Interv Cardiol; 2008 Feb; 21(1):28-31. PubMed ID: 18254787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
